Immediate Impact
59 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Advances in targeting histone deacetylase for treatment of solid tumors
2024 Standout
Works of Chiao Lo being referenced
ERα-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer
2018
From bench to bedside: What do we know about hormone receptor-positive and human epidermal growth factor receptor 2-positive breast cancer?
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Chiao Lo | 99 | 114 | 93 | 27 | 358 | |
| L. R. Jarvis | 116 | 99 | 42 | 25 | 387 | |
| F Skjørten | 44 | 43 | 89 | 30 | 348 | |
| Rohaizak Muhammad | 153 | 66 | 46 | 33 | 363 | |
| Nikoletta Sidiropoulos | 72 | 158 | 111 | 20 | 325 | |
| Christoph Fraune | 136 | 65 | 97 | 28 | 321 | |
| Jean-Lambert Pasteels | 125 | 77 | 81 | 19 | 345 | |
| Xiaona Chang | 137 | 103 | 49 | 46 | 401 | |
| Xiuhe Zou | 73 | 53 | 39 | 29 | 348 | |
| David Rageot | 65 | 131 | 47 | 18 | 386 | |
| Ioannis Flessas | 54 | 72 | 78 | 38 | 340 |
All Works
Login with ORCID to disown or claim papers
Loading papers...